Differential role and tissue specificity of interleukin-1α gene expression in atherogenesis and lipid metabolism

被引:94
作者
Kamari, Yehuda
Werman-Venkert, Rachel
Shaish, Aviv
Werman, Ariel
Harari, Ayelet
Gonen, Ayelet
Voronov, Elena
Grosskopf, Itamar
Sharabi, Yehonatan
Grossman, Ehud
Iwakura, Yoichiro
Dinarello, Charles A.
Apte, Ron N.
Harats, Dror [1 ]
机构
[1] Tel Aviv Univ, Tel Hashomer & Sackler Fac Med, Sheba Med Ctr, Inst Lipid & Atheresclerosis Res, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Tel Hashomer & Sackler Fac Med, Sheba Med Ctr, Hypertens Unit, IL-52621 Tel Hashomer, Israel
[3] Ben Gurion Univ Negev, Dept Microbiol & Immunol, Beer Sheva, Israel
[4] Univ Colorado, Dept Med, Denver, CO USA
[5] Ctr Med Expt, Inst Med Sci, Tokyo, Japan
关键词
atherosclerosis; inflammation; cytokines; IL-1; alpha; beta;
D O I
10.1016/j.atherosclerosis.2006.11.026
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We examined the role of IL-1 alpha and IL-1 beta expressed by bone marrow-derived cells in atherogenesis and lipid metabolism. Methods and results: We first studied the effect of atherogenic diet on wild-type C57BL/6 IL-1 alpha. or IL-1 beta deficient mice. IL-1 alpha KO resulted in a comparatively higher total cholesterol levels, compared to WT and IL-1 beta KO mice (398 +/- 10; 266 +/- 19; 223 +/- 13mg/dl, respectively, p < 0.001), due to higher non-HDL cholesterol. Nevertheless, aortic sinus lesion area was 56% lower in IL-1 alpha KO (p < 0.05) and 50% lower in ILAP KO(p=0.08), compared to WT mice. Likewise, SAA levels in IL-1 alpha KO mice were markedly lower compared to WT and IL-1 beta KO mice (31 +/- 14; 220 +/- 33 and 106 +/- 39 mu g/ml, respectively, p < 0.001). To study the specific role of bone marrow-derived IL-1, irradiated C57BL/6 mice were transplanted with either IL-1+/+. IL-1 alpha-/- or IL-1 beta-/- bone marrow cells. Despite similar lipoprotein levels, aortic sinus lesion area was 59% lowerin IL-1 alpha--/- transplanted (P < 0.05) compared to IL-1+/+ transplanted mice. Lesion area in IL-1 beta-/- was 33% lower than in IL-1+/+ recipient mice, but it was not statistically significant. Conclusion: We demonstrated that early lesion formation is accelerated specifically by bone marrow-derived IL-1 alpha. Furthermore, we showed that the expression of IL-1 alpha in cells other than the bone marrow plays a significant role in non-HDL cholesterol metabolism. (c) 2006 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:31 / 38
页数:8
相关论文
共 39 条
  • [1] INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY
    AREND, WP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) : 1445 - 1451
  • [2] INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS
    BEVILACQUA, MP
    POBER, JS
    MAJEAU, GR
    COTRAN, RS
    GIMBRONE, MA
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) : 618 - 623
  • [3] Targeting IL-1 in inflammatory disease: New opportunities for therapeutic intervention
    Braddock, M
    Quinn, A
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (04) : 1 - 10
  • [4] Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?
    Chait, A
    Han, CY
    Oram, JF
    Heinecke, JW
    [J]. JOURNAL OF LIPID RESEARCH, 2005, 46 (03) : 389 - 403
  • [5] Interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and/or a high-fat diet in a murine apolipoprotein E heterozygote model - Pharmacotherapeutic implications
    Chi, HH
    Messas, E
    Levine, RA
    Graves, DT
    Amar, S
    [J]. CIRCULATION, 2004, 110 (12) : 1678 - 1685
  • [6] INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4
    COLOTTA, F
    RE, F
    MUZIO, M
    BERTINI, R
    POLENTARUTTI, N
    SIRONI, M
    GIRI, JG
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    [J]. SCIENCE, 1993, 261 (5120) : 472 - 475
  • [7] Genetic alterations of IL-1 receptor antagonist in mice affect plasma cholesterol level and foam cell lesion size
    Devlin, CM
    Kuriakose, G
    Hirsch, E
    Tabas, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (09) : 6280 - 6285
  • [8] Interleukin-1 receptor antagonist expression in human endothelial cells and atherosclerosis
    Dewberry, R
    Holden, H
    Crossman, D
    Francis, S
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (11) : 2394 - 2400
  • [9] Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005
  • [10] Biologic basis for interleukin-1 in disease
    Dinarello, CA
    [J]. BLOOD, 1996, 87 (06) : 2095 - 2147